BioSpace News Archive

Press Releases

Scribe Therapeutics Presents Data on its Epigenetic Long-Term X-Repressor Technology at the 2025 Keystone Symposia on Precision Genome Engineering Conference

March 7, 2025
·
3 min read
Press Releases

ILUMYA® (tildrakizumab-asmn) Found Effective for Treatment of Moderate-to-Severe Plaque Psoriasis Affecting Nails in Study Presented at 2025 AAD Conference

March 7, 2025
·
6 min read
Press Releases

SFA Therapeutics Announces Positive Phase 1b Data of SFA-002 in Mild-to-Moderate Psoriasis

March 7, 2025
·
3 min read
Press Releases

Vertex Announces UK MHRA Approval of ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

March 7, 2025
·
7 min read
Press Releases

Torqur AG Presents Interim Phase 2 Clinical Trial Results at American Academy of Dermatology (AAD) 2025 Annual Meeting

March 7, 2025
·
5 min read
Press Releases

Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering

March 7, 2025
·
5 min read
Press Releases

Artax Biopharma Presents New Preclinical Data on Nck Modulators at 2025 AAD Annual Meeting

March 7, 2025
·
4 min read
Press Releases

CENTENE TO PRESENT AT BARCLAYS 27TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

March 7, 2025
·
1 min read
Press Releases

Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025

March 7, 2025
·
1 min read
Press Releases

Oruka Therapeutics Announces Preclinical Data for ORKA-002 at the 2025 American Academy of Dermatology Annual Meeting

March 7, 2025
·
5 min read